EPS8 regulates proliferation, apoptosis and chemosensitivity in BCR-ABL positive cells via the BCR-ABL/PI3K/AKT/mTOR pathway
Rui Huang(Wenzhou Medical University), Yuhua Li(Guangzhou University of Chinese Medicine), Yiran Chen(China Association of Acupuncture-Moxibustion), Jilong Yang(Tianjin Medical University Cancer Institute and Hospital), Qian Kang(First Affiliated Hospital of Henan University), Huimin Liu(Zhujiang Hospital), Xuan Zhou(Tianjin Medical University Cancer Institute and Hospital), Lei Wang(Shanghai University of Traditional Chinese Medicine), Yingzhi He, Yanjie He(Zhujiang Hospital), Anqin Wu(Zhujiang Hospital), Sanfang Tu(Zhujiang Hospital)
Cited by 20
Related Papers
Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status
|Laboratory Investigation|2010|362
Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies
|Journal of Experimental & Clinical Cancer Research|2021|267
CRISPR screens uncover protective effect of PSTK as a regulator of chemotherapy-induced ferroptosis in hepatocellular carcinoma
|Molecular Cancer|2022|139
Therapeutic vaccination against leukaemia via the sustained release of co-encapsulated anti-PD-1 and a leukaemia-associated antigen
|Nature Biomedical Engineering|2020|86
PD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacy
|Journal for ImmunoTherapy of Cancer|2021|85